For all its upheaval at the board level by way of a boohoo Group plc-led coup, analysts at Liberum have outlined a compelling investment thesis on Revolution Beauty.
It involves a strategic plan that aims to significantly enhance the company's market value through ambitious growth targets and operational efficiencies.
TUI AG (LSE:TUI)'s first quarter performance was even stronger than anticipated, according to Deutsche Bank, which repeated its 'buy' advice and 900p price target in the wake of the update.
Supporting its investment thesis, Deutsche said the travel giant's stock trades at a "very significant discount" to its historic valuation and said it underperformed its main stock market benchmarks so far this year.
The healthcare team at Citi has turned positive on GSK PLC (LSE:GSK, NYSE:GSK) for the first time in seven years.
Pushing the investment bank's analysts over the precipice to 'buy' was the outlook for belantamab mafodotin, (known as Blenrep for short), the drug giant's treatment for the blood disease myeloma.